FDA approvals of these biosimilars started in 2016, but only 1 such product has successfully launched.
Lisa Cristofaro, PharmD, BS, BCACP
Advertisement
Articles by Lisa Cristofaro, PharmD, BS, BCACP
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Dermatology Times
1
Clascoterone 5% Delivers Strong Phase 3 Hair-Growth Results
2
Top 5 Articles of the Week: November 30-December 5
3
The Weekly Roundup: December 1-5
4
ICYMI: First Patient Dosed in Global Phase 2 Study of Oral TYK2 Inhibitor Soficitinib for PN
5
